13 results match your criteria: "Portsmouth Hospitals National Health Service Trust[Affiliation]"

Article Synopsis
  • The ENHANCE study assessed the efficacy and safety of seladelpar, a PPAR-δ agonist, in patients with primary biliary cholangitis who didn't respond well to or couldn't tolerate traditional treatment with UDCA.
  • Participants were divided into three groups receiving either seladelpar (5 mg or 10 mg) or a placebo, with the primary goal of measuring liver function improvements after 12 months.
  • Results showed that patients receiving 10 mg of seladelpar had significant liver function improvements and reduced itching compared to placebo, and the treatment was deemed safe with no serious side effects reported.
View Article and Find Full Text PDF
Article Synopsis
  • Targeted biologic therapies, such as adalimumab, can provoke the creation of antidrug antibodies (ADA), leading to treatment failures in immune-mediated diseases.
  • This study focused on identifying genetic variations that make certain patients more likely to develop ADA against adalimumab, particularly in psoriasis patients on their first treatment course.
  • The researchers found specific genetic markers in the major histocompatibility complex (MHC) that correlate with resistance to ADA development, suggesting that these markers play a key role in the effectiveness of biologic therapies.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the efficacy and safety of seladelpar, a medication for adults with primary biliary cholangitis (PBC) who are at risk of worsening disease, especially those intolerant to standard medication, ursodeoxycholic acid.
  • Over 52 weeks, patients were given varying doses of seladelpar, showing significant reductions in alkaline phosphatase (ALP) levels, a marker of liver disease, particularly at higher doses (10 mg/day). Improvements were maintained over time.
  • Results indicated that seladelpar was effective in improving liver function and reducing symptoms like pruritus (itching) without serious side effects, making it a promising option for PBC patients
View Article and Find Full Text PDF

Robotic Low Anterior Resection.

Dis Colon Rectum

February 2021

Portsmouth Hospitals National Health Service Trust, Queen Alexandra Hospital, Hampshire, United Kingdom.

View Article and Find Full Text PDF

We present this case of human herpes virus 8-positive germinotropic lymphoproliferative disorder in a 20-year-old woman seen in the surgical oncology clinic for localised lymphadenopathy. This is the first case to be reported in the UK, and we discuss it along with a literature review including investigations and treatment options. This will demonstrate the importance of preoperative workup and multidisciplinary teamwork in deciding management plans and serve as a guide for future encounters of this rare condition in clinical practice.

View Article and Find Full Text PDF

Background: Carboplatin and paclitaxel administered every 3 weeks is standard-of-care first-line chemotherapy for epithelial ovarian cancer. The Japanese JGOG3016 trial showed a significant improvement in progression-free and overall survival with dose-dense weekly paclitaxel and 3-weekly carboplatin. In this study, we aimed to compare efficacy and safety of two dose-dense weekly regimens to standard 3-weekly chemotherapy in a predominantly European population with epithelial ovarian cancer.

View Article and Find Full Text PDF

Background: Remote ischaemic conditioning with transient ischaemia and reperfusion applied to the arm has been shown to reduce myocardial infarct size in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). We investigated whether remote ischaemic conditioning could reduce the incidence of cardiac death and hospitalisation for heart failure at 12 months.

Methods: We did an international investigator-initiated, prospective, single-blind, randomised controlled trial (CONDI-2/ERIC-PPCI) at 33 centres across the UK, Denmark, Spain, and Serbia.

View Article and Find Full Text PDF

Background: There are an estimated three million people in the United Kingdom with chronic obstructive pulmonary disease (COPD), and the incidence of bronchiectasis is estimated at around 0.1% but is more common in COPD and severe asthma. Both COPD and bronchiectasis are characterized by exacerbations in which bacteria play a central role.

View Article and Find Full Text PDF

Importance: Norepinephrine is currently recommended as the first-line vasopressor in septic shock; however, early vasopressin use has been proposed as an alternative.

Objective: To compare the effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock.

Design, Setting, And Participants: A factorial (2×2), double-blind, randomized clinical trial conducted in 18 general adult intensive care units in the United Kingdom between February 2013 and May 2015, enrolling adult patients who had septic shock requiring vasopressors despite fluid resuscitation within a maximum of 6 hours after the onset of shock.

View Article and Find Full Text PDF

Purpose: The IGFALS gene encodes the acid-labile subunit (ALS) protein, which regulates circulating IGF-1. Human IGFALS mutations cause growth hormone insensitivity (GHI) associated with ALS, IGF-1 and IGFBP-3 deficiencies and mild to moderate postnatal growth impairment (height SDS -2 to -4). Prenatal growth impairment is not a recognised feature of this disorder, but heterozygous carriers may show an intermediate phenotype.

View Article and Find Full Text PDF

Importance: Patients with neuromyelitis optica who have aquaporin-4 antibodies are being identified and receiving immunosuppressant treatment earlier and more aggressively as a result of increasing awareness of the importance of preventing relapses responsible for the high morbidity and mortality associated with the disease. To our knowledge, opportunistic retinal infection in patients with aquaporin-4 antibodies who are receiving immunosuppressants has not been reported to date.

Observations: We describe 2 patients with aquaporin-4 antibodies who were receiving conventional doses of first-line immunosuppressive therapy.

View Article and Find Full Text PDF

Respiratory responses to cold water immersion: neural pathways, interactions, and clinical consequences awake and asleep.

J Appl Physiol (1985)

June 2006

Institute of Biomedical and Biomolecular Sciences, Department of Sport and Exercise Science, St. Michael's Bldg., University of Portsmouth, White Swan Road, and Portsmouth Hospitals National Health Service Trust, UK PO1 2DT.

The ventilatory responses to immersion and changes in temperature are reviewed. A fall in skin temperature elicits a powerful cardiorespiratory response, termed "cold shock," comprising an initial gasp, hypertension, and hyperventilation despite a profound hypocapnia. The physiology and neural pathways of this are examined with data from original studies.

View Article and Find Full Text PDF